Acasti Pharma
ACST

股本结构

单位：万股
公告日期 2024-08-09 2023-11-13 2023-08-11 2023-07-07 2022-11-14 2022-09-29
证券总股本 1013.99 939.94 744.80 740.00 4461.28 4461.19
普通股本 1013.99 939.94 744.80 740.00 4461.28 4461.19
优先股 未披露 未披露 未披露 未披露 未披露 未披露
其他 未披露 未披露 未披露 未披露 未披露 未披露
变动日期 2024-06-30 2023-09-30 2023-08-09 2023-07-10 2022-11-14 2022-08-24
注释：中概股证券总股本=普通股股本/ 存托凭证比例

历史变动

公告日期 变动后普通股本（万股） 变动后优先股（万股） 变动原因 变动日期
2024-08-09 1013.99 未披露
更多>>
From March 31, 2024 to June 30, 2024 Issuance of common shares upon cashless exercise of pre-funded warrants
2024-06-30
2023-11-13 939.94 未披露
更多>>
From June 30, 2023 to September 30, 2023 Issuance of common shares and pre-funded warrants through private placement, net of offering costs Issuance of common shares upon the exercise of stock options
2023-09-30
2023-08-11 744.80 未披露 定期报告 2023-08-09
2023-07-07 740.00 未披露
更多>>
Acasti Pharma Inc. announced that the Company will effect a 1-for-6 reverse split of its issued and outstanding common shares.
2023-07-10
2022-11-14 4461.28 未披露 定期报告 2022-11-14
2022-09-29 4461.19 未披露 定期报告 2022-08-24
2022-08-11 4449.42 未披露
更多>>
From March 31, 2022 to June 30, 2022 Net proceeds from shares issued under the at-the-market (ATM) program
2022-06-30
2022-06-21 4443.98 未披露 定期报告 2022-06-21
2021-11-10 4428.82 未披露
更多>>
From June 30, 2021 to September 30, 2021 Common shares issued in relation to merger with Grace via share-for-share
2021-09-30
2021-08-27 4428.82 未披露
更多>>
Acasti’s board of directors has set the Reverse Stock Split ratio at 1-8.
2021-08-31
2021-08-27 35430.54 未披露
更多>>
On August 27, 2021, Acasti Pharma Inc. (“Acasti”) completed its previously announced business combination with Grace Therapeutics Inc. Immediately after the Merger and before giving effect to the Reverse Stock Split (as described herein), there were 354,305,416 Acasti common shares outstanding, of which Acasti’s existing shareholders owned approximately 59% and the former securityholders of Grace owned approximately 41%.
2021-08-27
2021-07-01 20837.55 未披露 定期报告 2021-06-29
2021-06-22 20837.55 未披露
更多>>
From March 31, 2020 To March 31, 2021 Warrants exercised Net proceeds from shares issued under the at-the-market (ATM) program Stock based compensation
2021-03-31
2021-03-09 20011.97 未披露 定期报告 2021-03-05
2021-02-09 17949.57 未披露 定期报告 2021-02-09
2021-02-09 15607.38 未披露
更多>>
From September 30, 2020 to December 31, 2020 Net proceeds from shares issued under the at-the-market (ATM) program
2020-12-31
2020-11-16 9689.25 未披露 定期报告 2020-11-16
2020-11-16 9686.91 未披露
更多>>
From June 30, 2020 to September 30, 2020 Net proceeds from shares issued under the at-the-market (ATM) program Stock based compensation
2020-09-30
2020-08-13 9689.25 未披露 定期报告 2020-08-13
2020-08-13 9248.84 未披露
更多>>
From March 31, 2020 to June 26, 2020 Net proceeds from shares issued under the at-the-market (ATM) program
2020-06-26
2020-06-29 9020.94 未披露
更多>>
From March 31, 2019 to February 13, 2020 Warrants exercised Net proceeds from shares issued under the at-the-market (ATM) program Shares issued as a settlement Stock based compensation
2020-02-13
2020-02-14 8905.78 未披露
更多>>
from September 30, 2019 to December 31, 2019 Net proceeds from shares issued under the at-the-market (ATM) program Shares issued upon warrants exercised Share-based payment transactions
2019-12-31
2019-08-14 8481.77 未披露 定期报告 2019-08-12
2019-08-06 7920.27 未披露 定期报告 2019-07-23
2019-08-14 7905.57 未披露
更多>>
from March 31, 2019 to June 30, 2019 Shares issued as settlement Warrants exercised Share-based payment transactions
2019-06-30
2019-06-26 7813.27 未披露
更多>>
from March 31, 2018 to March 31, 2019 Public offering Warrants exercised Share-based payment transactions Issuance of shares for payment of interest on convertible debentures
2019-03-31
2019-02-14 7812.86 未披露
更多>>
From December 31, 2017 to December 31, 2018 Public offering Warrants exercised Issuance of shares for payment of interest on convertible debentures
2018-12-31
2018-11-14 3667.99 未披露
更多>>
from March 31, 2018 to September 30, 2018 Public offering Issuance of shares for payment of interest on convertible debentures
2018-09-30
2018-08-01 3662.81 未披露 定期报告 2018-07-24
2018-08-14 3662.81 未披露
更多>>
from March 31, 2018 to June 27, 2018 Public offering Issuance of shares for payment of interest on convertible debentures
2018-06-27
2018-06-27 2563.82 未披露
更多>>
from March 31, 2017 to March 31, 2018 Public offering Warrants exercised Issuance of shares for payment of interest on convertible debentures
2018-03-31
2018-03-06 2560.46 未披露 定期报告 2018-02-09
2018-02-14 2483.84 未披露
更多>>
from March 31, 2017 to December 31, 2017 Public offering Warrants exercised Issuance of shares for payment of interest on convertible debentures
2017-12-31
2017-12-15 1491.47 未披露 定期报告 2017-12-13
2017-11-24 1479.72 未披露 定期报告 2017-11-24
2017-11-14 1473.59 未披露
更多>>
from March 31, 2017 to September 30, 2017 Issuance of shares for payment of interest on convertible debentures
2017-09-30
2017-08-15 1471.21 未披露
更多>>
from March 31, 2017 to June 28, 2017 Issuance of shares for payment of interest on convertible debentures
2017-06-28
2017-06-27 1470.26 未披露
更多>>
from February 29, 2016 to March 31, 2017 Public offering Equity settled non-employee share-based payment Total contributions by and distributions to equity holders for the twelve-month period Total contributions by and distributions to equity holders for the thirteen-month period
2017-03-31
2016-05-31 1071.20 未披露
更多>>
from February 28, 2015 to February 29, 2016 Issuance of shares Share options exercised RSUs released The reverse split became effective at the open of trading on October 14, 2015 and the Common Shares began trading on NASDAQ and TSX on a reverse split-adjusted basis on such date.
2016-02-29
2015-10-14 10661.63 未披露
更多>>
from February 28, 2015 to August 31, 2015 Share options exercised RSUs released
2015-08-31
2015-07-13 10661.38 未披露 定期报告 2015-07-13
2015-06-16 10644.40 未披露
更多>>
from February 28, 2014 to February 28, 2015 Share options exercised RSUs released
2015-02-28
2014-10-14 10626.02 未披露
更多>>
from February 28, 2014 to July 15, 2014 Transactions with owners, recorded directly in equity:Share options exercised Transactions with owners, recorded directly in equity:RSUs released
2014-07-15
2014-05-22 10586.22 未披露
更多>>
from February 28, 2013 to February 28, 2014 Transactions with owners,recorded directly in equity; Public offering Private placement Issuance of shares on royalty prepayment Warrants exercised Share options exercised RSUs released
2014-02-28
2014-01-14 8558.64 未披露
更多>>
from February 28, 2013 to October 24, 2013 Contributions by and distribution to owners： Warrants exercised Issuance of shares Share options exercised
2013-10-24
2013-10-15 8557.14 未披露 定期报告 2013-10-15
2013-10-15 8026.03 未披露
更多>>
from February 28, 2013 to August 31, 2013 Issuance of shares Warrants exercised Share options exercised
2013-08-31
2013-07-15 7318.88 未披露
更多>>
From February 28, 2013 to May 31, 2013 Transactions with owners, recorded directly in equity - Contributions by and distributions to owners: Warrants exercised Transactions with owners, recorded directly in equity - Contributions by and distributions to owners: Share options exercised
2013-05-31
2013-05-30 7310.75 未披露
更多>>
From February 29, 2012 to February 28, 2013 Transactions with owners, recorded directly in equity - Contributions by and distributions to owners:Warrants exercised Transactions with owners, recorded directly in equity - Contributions by and distributions to owners:Share options exercised
2013-02-28
From March 31, 2024 to June 30, 2024 Issuance of common shares upon cashless exercise of pre-funded warrants
From June 30, 2023 to September 30, 2023 Issuance of common shares and pre-funded warrants through private placement, net of offering costs Issuance of common shares upon the exercise of stock options
Acasti Pharma Inc. announced that the Company will effect a 1-for-6 reverse split of its issued and outstanding common shares.
From March 31, 2022 to June 30, 2022 Net proceeds from shares issued under the at-the-market (ATM) program
From June 30, 2021 to September 30, 2021 Common shares issued in relation to merger with Grace via share-for-share
Acasti’s board of directors has set the Reverse Stock Split ratio at 1-8.
On August 27, 2021, Acasti Pharma Inc. (“Acasti”) completed its previously announced business combination with Grace Therapeutics Inc. Immediately after the Merger and before giving effect to the Reverse Stock Split (as described herein), there were 354,305,416 Acasti common shares outstanding, of which Acasti’s existing shareholders owned approximately 59% and the former securityholders of Grace owned approximately 41%.
From March 31, 2020 To March 31, 2021 Warrants exercised Net proceeds from shares issued under the at-the-market (ATM) program Stock based compensation
From September 30, 2020 to December 31, 2020 Net proceeds from shares issued under the at-the-market (ATM) program
From June 30, 2020 to September 30, 2020 Net proceeds from shares issued under the at-the-market (ATM) program Stock based compensation
From March 31, 2020 to June 26, 2020 Net proceeds from shares issued under the at-the-market (ATM) program
From March 31, 2019 to February 13, 2020 Warrants exercised Net proceeds from shares issued under the at-the-market (ATM) program Shares issued as a settlement Stock based compensation
from September 30, 2019 to December 31, 2019 Net proceeds from shares issued under the at-the-market (ATM) program Shares issued upon warrants exercised Share-based payment transactions
from March 31, 2019 to June 30, 2019 Shares issued as settlement Warrants exercised Share-based payment transactions
from March 31, 2018 to March 31, 2019 Public offering Warrants exercised Share-based payment transactions Issuance of shares for payment of interest on convertible debentures
From December 31, 2017 to December 31, 2018 Public offering Warrants exercised Issuance of shares for payment of interest on convertible debentures
from March 31, 2018 to September 30, 2018 Public offering Issuance of shares for payment of interest on convertible debentures
from March 31, 2018 to June 27, 2018 Public offering Issuance of shares for payment of interest on convertible debentures
from March 31, 2017 to March 31, 2018 Public offering Warrants exercised Issuance of shares for payment of interest on convertible debentures
from March 31, 2017 to December 31, 2017 Public offering Warrants exercised Issuance of shares for payment of interest on convertible debentures
from March 31, 2017 to September 30, 2017 Issuance of shares for payment of interest on convertible debentures
from March 31, 2017 to June 28, 2017 Issuance of shares for payment of interest on convertible debentures
from February 29, 2016 to March 31, 2017 Public offering Equity settled non-employee share-based payment Total contributions by and distributions to equity holders for the twelve-month period Total contributions by and distributions to equity holders for the thirteen-month period
from February 28, 2015 to February 29, 2016 Issuance of shares Share options exercised RSUs released The reverse split became effective at the open of trading on October 14, 2015 and the Common Shares began trading on NASDAQ and TSX on a reverse split-adjusted basis on such date.
from February 28, 2015 to August 31, 2015 Share options exercised RSUs released
from February 28, 2014 to February 28, 2015 Share options exercised RSUs released
from February 28, 2014 to July 15, 2014 Transactions with owners, recorded directly in equity:Share options exercised Transactions with owners, recorded directly in equity:RSUs released
from February 28, 2013 to February 28, 2014 Transactions with owners,recorded directly in equity; Public offering Private placement Issuance of shares on royalty prepayment Warrants exercised Share options exercised RSUs released
from February 28, 2013 to October 24, 2013 Contributions by and distribution to owners： Warrants exercised Issuance of shares Share options exercised
from February 28, 2013 to August 31, 2013 Issuance of shares Warrants exercised Share options exercised
From February 28, 2013 to May 31, 2013 Transactions with owners, recorded directly in equity - Contributions by and distributions to owners: Warrants exercised Transactions with owners, recorded directly in equity - Contributions by and distributions to owners: Share options exercised
From February 29, 2012 to February 28, 2013 Transactions with owners, recorded directly in equity - Contributions by and distributions to owners:Warrants exercised Transactions with owners, recorded directly in equity - Contributions by and distributions to owners:Share options exercised
同花顺个股页面 | 模拟炒股 | 股民学校 | 手机炒股| 联系我们

免责声明:本信息由同花顺金融研究中心提供，仅供参考，同花顺金融研究中心力求但不保证数据的完全准确，如有错漏请以中国证监会指定上市公司信息披露媒体为准，同花顺金融研究中心不对因该资料全部或部分内容而引致的盈亏承担任何责任。用户个人对服务的使用承担风险。同花顺对此不作任何类型的担保。同花顺不担保服务一定能满足用户的要求，也不担保服务不会受中断，对服务的及时性，安全性，出错发生都不作担保。同花顺对在同花顺上得到的任何信息服务或交易进程不作担保。同花顺提供的包括同花顺理财的所有文章，数据，不构成任何的投资建议，用户查看或依据这些内容所进行的任何行为造成的风险和结果都自行负责，与同花顺无关。

【免责声明】本产品中的行情数据及资讯信息来源于第三方，长江证券不对收集数据的版权、真实性、准确性及传输过程中发生的传送错误承担法律责任。本内容仅供参考，不作为投资决策依据，长江证券不对因据此操作产生的盈亏承担任何责任。投资有风险，入市需谨慎。